Mrs Alfreda E Paiva, SCHOOL PSYCHOLOGIST | |
139 Pancake Rd, Andover, NH 03216-3129 | |
(603) 530-1076 | |
Not Available |
Full Name | Mrs Alfreda E Paiva |
---|---|
Gender | Female |
Speciality | Psychologist - School |
Location | 139 Pancake Rd, Andover, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922626613 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Alfreda E Paiva, SCHOOL PSYCHOLOGIST 139 Pancake Rd, Andover, NH 03216-3129 Ph: (603) 530-1076 | Mrs Alfreda E Paiva, SCHOOL PSYCHOLOGIST 139 Pancake Rd, Andover, NH 03216-3129 Ph: (603) 530-1076 |
News Archive
It is second nature for most of us that exercise protects against heart attack and stroke, but researchers have spent 30 years unraveling the biochemistry behind the idea. One answer first offered by researchers at the University of Rochester Medical Center is that athletic hearts push blood through arteries with greater force, which alone triggers reactions that protect against dangerous clogs in blood vessels.
Everybody knows sleep is good for your body. It may be good for your mind, too. That's what scientists at Wake Forest School of Medicine will attempt to determine thanks to a $5.3 million grant from the National Institute on Aging, part of the National Institutes of Health.
The U.S. Food and Drug Administration announced that today Real Water Inc., a Nevada-based bottled water manufacturer, agreed to cease operations until they can comply with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and other requirements listed in a consent decree.
Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).
› Verified 8 days ago